In Vivo is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
QDose has licensed Bristol-Myers Squibb worldwide exclusive rights to its breath-activated, inhaled insulin product candidate. QDose is a JV owned by drug delivery company MicroDose Technologies and Quadrant Drug Delivery Ltd. (QDD; dry powder pulmonary delivery), the July 2003 management buyout of the former Elan Drug Delivery Ltd.
R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?